Express Pharma - Page 1635 of 2247 - Express Pharma

Lupin launches Raltegravir Tablets USP, 600 mg in the US

Lupin appoints Akhil Gupta as Independent Director to its Board

India’s life sciences and healthcare sectors raise $173m in October 2026

CPhI and P-MEC India

Weeding out the bad FDCs

Natco Pharma to sell US-based pharmacy stores

Gujarat State TB Association, Sparsh and Cadila Pharma organise medical camps

Videojet launches Pharma Hub web portal

Express Pharma (Vol.11, No.11) April 1-15, 2016

Lupin clarifies on from 483s issued by US FDA for its Mandideep facility

Govt’s decision to ban 344 FDCs was taken without consideration: Pharma cos to Delhi HC

Sun Pharma enters Japanese prescription market

Jubilant Innovation USA to receive up to $22.6 m over acquisition of drug development firm